Lead Product(s) : Norbaeocystin
Therapeutic Area : Psychiatry/Psychology
Study Phase : Phase I
Sponsor : Advanced Biofuels
Deal Size : Undisclosed
Deal Type : Collaboration
PsyBio Therapeutics Initiates Process Development of Proprietary Biosynthetic Norbaeocystin
Details : Norbaeocystin is an analogue of psilocybin and is not a controlled substance. The Company has commenced Phase I of this process, including analytical chemistry technical transfer to establish detection methods for fermentation products and key feedstocks...
Product Name : Undisclosed
Product Type : Small molecule
Upfront Cash : Undisclosed
March 23, 2021
Lead Product(s) : Norbaeocystin
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Phase I
Sponsor : Advanced Biofuels
Deal Size : Undisclosed
Deal Type : Collaboration
LOOKING FOR A SUPPLIER?